31 Mar China’s first-quarter IPOs plunge 65% as regulator’s focus on listing quality saps pipeline
Twenty-eight companies have raised a total of 23 billion yuan (US$3.18 billion) by selling new shares on the mainland’s three exchanges, compared with 68 listings that raised 65.1 billion yuan in the first three months of 2023, according to Bloomberg data.
These steps add to measures that have been in place since August to slow the pace of new offerings to bolster investors’ confidence.
“The slowdown in IPOs will carry on, and the listing process for mega IPOs is expected to be lengthened,” said Wang Zhengzhi, an analyst at Guotai Junan Securities in Shanghai. “The purpose is to guard against risks and promote the high-quality development of the capital market.”
The biggest IPO this year is Grandtop Yongxing Group, a Guangdong province-based waste treatment company that started trading in Shanghai on January 18 after raising 2.43 billion yuan, Bloomberg data shows. That is about half the size of the most valuable deal in the January-March period in 2023, when Hunan Yuneng New Energy Battery Material raked in 4.5 billion yuan on the Shenzhen bourse. Grandtop now trades at about 18 per cent below its offer price of 16.20 yuan.
China’s ‘broker butcher’ vows to tighten IPO rules, curb false accounting
China’s ‘broker butcher’ vows to tighten IPO rules, curb false accounting
Increased regulatory surveillance has already led an increasing number of companies to recoil from IPOs: 73 companies have withdrawn IPO applications in the year to date, according to statistics gathered by Shanghai Securities News. Some 184 companies did so in the whole of 2023.
Syngenta withdraws Shanghai IPO application amid slowing China equities market
Syngenta withdraws Shanghai IPO application amid slowing China equities market
“After careful consideration of the industry environment and the company’s own development strategy, Syngenta has decided to withdraw its application for an IPO on the main board of the Shanghai Stock Exchange,” the company said in a notice to the exchange.
The Shanghai Stock Exchange said it had terminated a review of the company’s initial public offering (IPO) application after Syngenta applied to withdraw its IPO.
The CSRC will link the pace of new share sales to the performance of the secondary market and members of listing committees will have lifelong responsibility for malfeasance, the watchdog said in one of four policy documents it issued this month.
“That will reinforce the market’s expectations about tighter supply of new shares,” said Li Hui, an analyst at Huajin Securities.